CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETQ
376
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $4.48K | ﹤0.01% |
392
+98
| +33% | +$1.12K |
|
377
Stoke Therapeutics
STOK
$1.11B
| $4.46K | ﹤0.01% |
535
+134
| +33% | +$1.12K |
|
378
Lucid Motors
LCID
$57.9B
| $4.45K | ﹤0.01% |
+554
| New | +$4.45K |
|
379
XPeng
XPEV
$19.9B
| $4.44K | ﹤0.01% |
400
| – | – |
|
|
BLUE
380
DELISTED
bluebird bio
BLUE
| $4.44K | ﹤0.01% |
1,395
+553
| +66% | +$1.76K |
|
381
Caribou Biosciences
CRBU
$180M
| $4.39K | ﹤0.01% |
827
+207
| +33% | +$1.1K |
|
382
Kodiak Sciences
KOD
$465M
| $4.39K | ﹤0.01% |
708
+176
| +33% | +$1.09K |
|
383
Design Therapeutics
DSGN
$326M
| $4.37K | ﹤0.01% |
758
+190
| +33% | +$1.1K |
|
384
Humacyte
HUMA
$245M
| $4.32K | ﹤0.01% |
1,398
+351
| +34% | +$1.09K |
|
385
Rivian
RIVN
$16.3B
| $4.3K | ﹤0.01% |
+278
| New | +$4.3K |
|
386
Phibro Animal Health
PAHC
$1.44B
| $4.23K | ﹤0.01% |
276
+69
| +33% | +$1.06K |
|
|
NIU
387
Niu Technologies
NIU
$338M
| $4.14K | ﹤0.01% |
1,000
| – | – |
|
388
ATAI Life Sciences
ATAI
$1.01B
| $4.07K | ﹤0.01% |
2,248
+563
| +33% | +$1.02K |
|
389
Phathom Pharmaceuticals
PHAT
$863M
| $4.03K | ﹤0.01% |
564
+141
| +33% | +$1.01K |
|
390
Sangamo Therapeutics
SGMO
$165M
| $4.02K | ﹤0.01% |
2,283
+618
| +37% | +$1.09K |
|
391
Omeros
OMER
$293M
| $3.95K | ﹤0.01% |
850
+213
| +33% | +$991 |
|
392
PepGen
PEPG
$40M
| $3.91K | ﹤0.01% |
320
+80
| +33% | +$979 |
|
393
Atea Pharmaceuticals
AVIR
$271M
| $3.78K | ﹤0.01% |
1,129
+283
| +33% | +$948 |
|
394
Atara Biotherapeutics
ATRA
$84.6M
| $3.77K | ﹤0.01% |
1,300
+336
| +35% | +$974 |
|
|
KNTE
395
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.74K | ﹤0.01% |
598
+150
| +33% | +$938 |
|
396
Prelude Therapeutics
PRLD
$68.5M
| $3.7K | ﹤0.01% |
649
+279
| +75% | +$1.59K |
|
397
Codexis
CDXS
$244M
| $3.7K | ﹤0.01% |
893
+225
| +34% | +$931 |
|
|
HLTH
398
DELISTED
Cue Health Inc. Common Stock
HLTH
| $3.68K | ﹤0.01% |
2,024
+506
| +33% | +$921 |
|
399
Precigen
PGEN
$1.42B
| $3.61K | ﹤0.01% |
3,401
+1,287
| +61% | +$1.36K |
|
400
Sutro Biopharma
STRO
$83.8M
| $3.6K | ﹤0.01% |
779
+196
| +34% | +$906 |
|